000 | 01568 a2200421 4500 | ||
---|---|---|---|
005 | 20250513203331.0 | ||
264 | 0 | _c20000410 | |
008 | 200004s 0 0 eng d | ||
022 | _a0026-895X | ||
024 | 7 |
_a10.1124/mol.57.3.595 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMurphy, C T | |
245 | 0 | 0 |
_amyo-inositol 1,4,6-trisphosphorothioate and myo-inositol 1,3, 6-trisphosphorothioate: partial agonists with very low intrinsic activity at the platelet myo-inositol 1,4,5-trisphosphate receptor. _h[electronic resource] |
260 |
_bMolecular pharmacology _cMar 2000 |
||
300 |
_a595-601 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
650 | 0 | 4 |
_aCalcium _xmetabolism |
650 | 0 | 4 |
_aCalcium Channels _xmetabolism |
650 | 0 | 4 |
_aCell Membrane _xdrug effects |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aInositol 1,4,5-Trisphosphate _xanalogs & derivatives |
650 | 0 | 4 | _aInositol 1,4,5-Trisphosphate Receptors |
650 | 0 | 4 |
_aOrganothiophosphorus Compounds _xpharmacology |
650 | 0 | 4 | _aPermeability |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xmetabolism |
650 | 0 | 4 | _aTritium |
700 | 1 | _aRiley, A M | |
700 | 1 | _aMills, S J | |
700 | 1 | _aLindley, C J | |
700 | 1 | _aPotter, B V | |
700 | 1 | _aWestwick, J | |
773 | 0 |
_tMolecular pharmacology _gvol. 57 _gno. 3 _gp. 595-601 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1124/mol.57.3.595 _zAvailable from publisher's website |
999 |
_c10646700 _d10646700 |